About Panchsheel Organics Ltd
Panchsheel Organics principal business is manufacturing and trading of Bulk Drug and Intermediate.
Founded
1989
CEO
Mahendra Turakhia
Employees
185
HQ
Mumbai, India
Finished Products
1Bulk Drugs
₹196.47Cr2Bulk Drugs & Chemicals
₹88.96Cr3Bulk Drugs-Traded
₹26.92Cr4Formulations-Traded
₹2.63Cr5DEPB Licence
₹0.50Cr6Other Operating Income
₹0.09Cr7Other Income
₹0.01CrRaw Materials
1Raw Material Consumed
₹143.07Cr2Packing Material
₹0.43CrAbout Panchsheel Organics Ltd
Panchsheel Organics principal business is manufacturing and trading of Bulk Drug and Intermediate.
Founded:1989
CEO:Mahendra Turakhia
Employees:185
HQ:Mumbai, India
Finished Products
1Bulk Drugs
₹196.47Cr2Bulk Drugs & Chemicals
₹88.96Cr3Bulk Drugs-Traded
₹26.92Cr4Formulations-Traded
₹2.63Cr5DEPB Licence
₹0.50Cr6Other Operating Income
₹0.09Cr7Other Income
₹0.01CrRaw Materials
1Raw Material Consumed
₹143.07Cr2Packing Material
₹0.43CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹157
52W Low
₹86
Volume15.19K
Avg VolumeN/A
Beta1.22
Dividend Yield0.69%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
14.90x
Valuation
P/B Ratio
1.09x
Valuation
EPS
₹7.82
Valuation
Dividend Yield
0.69%
Valuation
ROE
7.69%
Profitability
ROCE
9.73%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and Trading of Bulk DRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
98.7%
International
1.3%
Country of domicile (India)98.7%
Foreign countries1.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.04x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
1.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.